PT1989295T - Processo para diferenciação osteogénica de células estaminais de medula óssea (cemo) e as suas utilizações - Google Patents

Processo para diferenciação osteogénica de células estaminais de medula óssea (cemo) e as suas utilizações

Info

Publication number
PT1989295T
PT1989295T PT77115616T PT07711561T PT1989295T PT 1989295 T PT1989295 T PT 1989295T PT 77115616 T PT77115616 T PT 77115616T PT 07711561 T PT07711561 T PT 07711561T PT 1989295 T PT1989295 T PT 1989295T
Authority
PT
Portugal
Prior art keywords
bmsc
stem cells
bone marrow
marrow stem
osteogenic differentiation
Prior art date
Application number
PT77115616T
Other languages
English (en)
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Publication of PT1989295T publication Critical patent/PT1989295T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT77115616T 2006-02-16 2007-02-16 Processo para diferenciação osteogénica de células estaminais de medula óssea (cemo) e as suas utilizações PT1989295T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2006001427 2006-02-16

Publications (1)

Publication Number Publication Date
PT1989295T true PT1989295T (pt) 2020-10-29

Family

ID=36223371

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77115616T PT1989295T (pt) 2006-02-16 2007-02-16 Processo para diferenciação osteogénica de células estaminais de medula óssea (cemo) e as suas utilizações

Country Status (9)

Country Link
US (1) US8337827B2 (pt)
JP (1) JP5170443B2 (pt)
KR (1) KR20080109726A (pt)
CN (1) CN101384707A (pt)
CA (1) CA2640794C (pt)
DK (1) DK1989295T3 (pt)
ES (1) ES2830525T3 (pt)
PT (1) PT1989295T (pt)
WO (1) WO2007093431A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008109866A (ja) * 2006-10-30 2008-05-15 Jms Co Ltd 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法
US8062364B1 (en) 2007-04-27 2011-11-22 Knee Creations, Llc Osteoarthritis treatment and device
KR101618380B1 (ko) * 2007-12-21 2016-05-04 본 테라퓨틱스 소시에테아노님 염증성 류마티스 질환의 치료에 있어서의 인간 골-형성 세포
US20100278788A1 (en) * 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
KR20110013450A (ko) * 2008-05-07 2011-02-09 본 테라퓨틱스 소시에테아노님 간엽 줄기 세포 및 골-형성 세포
BE1018578A5 (fr) * 2008-05-07 2011-04-05 Bone Therapeutics Sa Cellules formatrices d'os humains dans le traitement d'etats et de maladies osseuses associes a une immunodeficience ou une immunosuppression.
EP2324359B1 (en) * 2008-08-18 2018-10-31 Mesoblast, Inc. Use of heat shock protein 90-beta as marker for the identification and/or enrichment of adult multipotential mesenchymal precursor cells
EP2344631B1 (en) * 2008-10-31 2019-10-16 Synthes GmbH Method and device for activating stem cells
WO2010132315A1 (en) * 2009-05-13 2010-11-18 Endgenitor Technologies, Inc. Enhanced hematopoietic stem cell engraftment
EP2258413A1 (en) 2009-06-04 2010-12-08 Université Catholique de Louvain Multi-dimensional biomaterial and method for producing the same.
WO2012048755A1 (en) 2010-10-15 2012-04-19 Université Libre de Bruxelles Er-alpha-17p peptide, effects on stem cell differentiation
US20140112891A1 (en) * 2011-04-08 2014-04-24 Neostem, Inc. AUTOLOGOUS HUMAN ADULT PLURIPOTENT VERY SMALL EMBRYONIC-LIKE (hVSEL) STEM CELL REGENERATION OF BONE AND CARTILAGE
SG11201401434TA (en) 2011-10-11 2014-09-26 Bone Therapeutics Sa Uses of growth and differentiation factor 8 (gdf-8)
JP2013153747A (ja) * 2012-01-27 2013-08-15 Sapporo Medical Univ 様々な疾患の治療のための骨芽ニッチ細胞の置換
US9486483B2 (en) * 2013-10-18 2016-11-08 Globus Medical, Inc. Bone grafts including osteogenic stem cells, and methods relating to the same
CN103611193B (zh) * 2013-11-26 2015-05-27 中山大学 一种碳酸钙微球-细胞外基质复合材料及其制备方法和应用
KR101518651B1 (ko) * 2013-12-31 2015-05-07 동국대학교 산학협력단 골 및 신생혈관 형성능이 향상된 줄기세포 공배양 방법
WO2016170112A1 (en) 2015-04-23 2016-10-27 Bone Therapeutics S.A. In vitro preservation of therapeutic cells
AU2017204355B2 (en) 2016-07-08 2021-09-09 Mako Surgical Corp. Scaffold for alloprosthetic composite implant
AU2018351804B2 (en) 2017-10-20 2020-07-09 Bone Therapeutics Sa Methods for differentiating mesenchymal stem cells
KR20210074303A (ko) 2018-09-25 2021-06-21 본 테라퓨틱스 소시에테아노님 중간엽 줄기 세포의 분화 방법
JP2022502034A (ja) 2018-09-25 2022-01-11 ボーン、セラピューティクス、エスアーBone Thrapeutics Sa ｉｎ ｖｉｔｒｏ分化細胞の骨形成能を決定するための方法および使用
KR20200036459A (ko) 2018-09-28 2020-04-07 (주)링크옵틱스 녹색 형광결합 CD133 단백질의 발현을 통한 전립선암 세포의 in vitro 및 in vivo 골전이 방법
CN116583594A (zh) * 2020-10-14 2023-08-11 奥瑟姆健康公司 用于骨髓的提取和低温保藏的***和方法
CN113599500A (zh) * 2021-08-04 2021-11-05 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) 一种治疗骨骼代谢性疾病的药物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US8075880B2 (en) * 1999-01-11 2011-12-13 Steward St. Elizabeth's Medical Center Of Boston, Inc. Compositions and methods for regulating angiogenesis
AU6144698A (en) 1997-02-05 1998-08-25 Case Western Reserve University Stimulatory effects of bfgf and bmp-2 on osteogenic differentiation of mesenchymal stem cells
ES2539105T3 (es) * 2001-07-06 2015-06-26 Asterias Biotherapeutics, Inc. Células mesenquimatosas y osteoblastos procedentes de células madre embrionarias humanas
JP2005532810A (ja) 2002-07-16 2005-11-04 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 組織修復および組織形成のために間葉性幹細胞を移植する方法

Also Published As

Publication number Publication date
CA2640794A1 (en) 2007-08-23
JP2009526534A (ja) 2009-07-23
US20090081169A1 (en) 2009-03-26
WO2007093431A1 (en) 2007-08-23
CA2640794C (en) 2015-04-14
KR20080109726A (ko) 2008-12-17
DK1989295T3 (da) 2020-09-28
ES2830525T3 (es) 2021-06-03
US8337827B2 (en) 2012-12-25
CN101384707A (zh) 2009-03-11
JP5170443B2 (ja) 2013-03-27

Similar Documents

Publication Publication Date Title
PT1989295T (pt) Processo para diferenciação osteogénica de células estaminais de medula óssea (cemo) e as suas utilizações
EP1915110A4 (en) MULTI-LUMENFORM FOR INTERVERTEBRAL PROSTHESIS AND USE METHOD
EP2088945A4 (en) INSTRUMENT SYSTEM FOR DYNAMIC SPEED IMPLANTS
IL196137A0 (en) Method for stem cell culture and cells derived therefrom
EP2094197A4 (en) METHOD AND APPARATUS FOR TOTAL HIP REPLACEMENT
EP2249719A4 (en) INSTRUMENTS AND METHODS FOR INTRODUCING ARTIFICIAL INTERVERTEBRAL IMPLANTS
EP1931287A4 (en) IMPLANT FOR BONE ALIGNMENT AND METHOD OF USE
GB0710095D0 (en) Culture method of stem cell
GB2438345B (en) An acetabular shell system and method for making
EP2066389A4 (en) BONE MARROW EXTRACTION DEVICES AND ASSOCIATED METHODS THEREOF
EP2010266A4 (en) INTEGRATED ACRYLIC CEMENT DELIVERY SYSTEM FOR BONE INCREASE PROCEDURES AND METHODS
EP2001410A4 (en) PROSTHETIC IMPLANT AND ITS ASSEMBLY METHOD
EP1998721A4 (en) BACKMARK IMPLANT WITH OFFSET KIEL
EP2117470A4 (en) BAND DISC IMPLANT DEVICE AND METHOD OF USE THEREOF
IL194970A0 (en) Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
GB0623801D0 (en) Orthopaedic implants and prosthesis
EP2040650A4 (en) PROCESS AND KIT FOR THE PRODUCTION OF A PROSTHESIS
EP2083757A4 (en) SYSTEM AND METHOD FOR REALIZING JOINT ARTHROPLASTY
EP2493426A4 (en) SYSTEM AND METHOD FOR A SWIVEL COLUMN IMPLANT ARRANGEMENT
IL196422A0 (en) Annuloplasty system and surgical method
EP2182887A4 (en) METHOD FOR IMPROVED DIFFERENTIATION OF MESENCHYMAL STEM CELLS ON THE BASIS OF A DOUBLE-STRUCTURED TISSUE IMPLANT
EP1744766A4 (en) COMPOSITION FOR STIMULATING BONE GROWTH AND DIFFERENTIATION AND CORRESPONDING METHOD
PL2229433T3 (pl) Osteogenne różnicowanie komórek macierzystych szpiku kostnego i mezenchymalnych komórek macierzystych z zastosowaniem kombinacji czynników wzrostu
EP2056919A4 (en) BONE TASTING APPARATUS AND METHOD THEREOF
EP2362761A4 (en) DEVICE AND METHOD FOR TREATING A FEMORO-ACETABULAR PINCH